This suggests that Dino may be a critical tissue-specific p53-associated tumor suppressor in the development of sarcoma, a finding supported by the mutual exclusivity between DINO silencing through DNA methylation and p53 mutational status in human sarcomas. The gene discussed is DINOL; the disease is sarcoma.